Skip to content

Ibex Prostate Detect 3.1-US

by Ibex Medical Analytics Ltd

Ibex Prostate Detect 3.1-US is a medical device (FDA Class II; FDA product code QPN, Software Algorithm Device To Assist Users In Digital Pathology) made by Ibex Medical Analytics Ltd, cleared under FDA 510(k) K241232 on 24 Jan 2025 and listed in FDA GUDID since 17 Jul 2025 (UDI-DI 07290019124016), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K241232

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number07290019124016 UDI-DI Date17 Jul 2025ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK241232 Date24 Jan 2025DecidedStatusActive

Official records

From the FDA record

Device description
Ibex Prostate Detect is a software only device intended to analyze scanned histopathology whole slide images (WSIs) from prostate core needle biopsies (PCNB) prepared from hematoxylin & eosin (H&E) stained formalin-fixed paraffin embedded (FFPE) tissue. The device is intended to identify cases initially diagnosed as benign for further review by a pathologist. If Ibex Prostate Detect detects tissue morphology suspicious for prostate adenocarcinoma (AdC), it provides case- and slide-level alerts (flags) which includes a heatmap of tissue areas in the WSI that is likely to contain cancer. Ibex Prostate Detect is intended to be used with slide images digitized with Philips Ultra Fast Scanner and visualized using the Ibex Prostate Detect user interface. Ibex Prostate Detect outputs are not intended to be used on a standalone basis for diagnosis, to rule out prostatic AdC or to preclude pathological assessment of WSIs according to the standard of care.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K241232 decided 24 Jan 2025 Active
  • FDA GUDID UDI-DI 07290019124016 listed 17 Jul 2025 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K241232
  2. Listed FDA GUDID 07290019124016

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Ibex Prostate Detect
Generic name
Histology/cytology/microbiology image-analysis interpretive software IVD
Model / reference
3.1-US
Primary DI / UDI-DI
07290019124016
510(k) Number
FDA product code
QPN
GMDN term
Histology/cytology/microbiology image-analysis interpretive software IVD
Device class
Class II
Regulation number
864.3750
GUDID distribution status
In Commercial Distribution

Other devices from Ibex Medical Analytics Ltd

See all devices from Ibex Medical Analytics Ltd →

Properties

  • Prescription use
  • Manufacturing date
Other properties (13, all answered No)